Home > Inhibitors & Agonists > Cell Cycle/DNA Damage > ATM/ATR
Cat. No. Product name CAS No.
DC10906 AZ31 Featured

AZ31 is a novel ATM inhibitor.

2088113-98-6
DC10891 AZ32 Featured

AZ32 is an orally bioavailable and blood-brain-barrier penetrating ATM inhibitor (AZ32) that radiosensitizes intracranial gliomas in mice.

DC9309 AZD-0156

AZD-0156 is an orally bioavailable ataxia telangiectasia mutated (ATM) kinase inhibitor, with potential chemo-/radio-sensitizing and antineoplastic activities.

1821428-35-6
DC8468 AZD-6738 Featured

AZD6738 is an orally active, and selective ATR kinase inhibitor with IC50 of 1 nM. Phase 1/2.

1352226-88-0
DC10526 BAY-1895344 Featured

BAY-1895344 is a potent and selective ATM inhibitor. BAY 1895344 shows potent anti-tumor efficacy in monotherapy and strong combination potential with the targeted alpha therapy Radium-223 dichloride.

1876467-74-1
DC4112 CP466722 Featured

CP-466722 is an potent and reversible ATM inhibitor.

1080622-86-1
DC10080 GJ103 sodium salt Featured

GJ103 sodium salt is an active analog of the read-through compound GJ072.

1459687-96-7
DC1067 KU-55933 Featured

KU-55933 is a potent and specific ATM inhibitor with IC50 and Ki of 13 nM and 2.2 nM, respectively.

587871-26-9
DC7448 KU-60019 Featured

KU-60019 is an improved analogue of KU-55933, with IC50 of 6.3 nM for ATM.

925701-46-8
DC3132 VE-821 Featured

VE-821 is a potent and selective ATP competitive inhibitor of ATR with Ki and IC50 of 13 nM and 26 nM, respectively.

1232410-49-9
Page 1 / Total 1 FirstPrevNextLastGoto